重新利用Imeglimin治疗化疗引起的认知障碍:针对线粒体功能障碍和神经炎症
Suresh Babu Kondaveeti1, Vrinda Gupta2, Harpreet Kaur2
1Symbiosis Medical College for Women, Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University), Pune, 412115, India. ksuresh.babu@smcw.siu.edu.in.
Cellular and molecular neurobiology
|February 10, 2026
概括
抗糖尿病药物Imeglimin在治疗化疗引起的认知障碍 (CICI) 或化疗大脑方面表现有前途. 它的神经保护作用对抗氧化应激和神经炎症,可能在癌症治疗后恢复认知功能.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 瘤学和癌症治疗学 癌症治疗学
背景情况:
- 化疗诱导的认知障碍 (CICI),或化疗大脑,显著影响记忆力,注意力和执行功能.
- 关键的CICI机制包括氧化应激,线粒体功能障碍,神经炎症,胰岛素耐药性和减少的神经发生.
研究的目的:
- 探索imeglimin,一种新型抗糖尿病药物的潜力,作为化疗大脑的治疗剂.
- 批判性地评估伊梅格林的机理性可信性,药理上的限制,以及缓解CICI的验证差距.
主要方法:
- 对伊梅格林的药理作用和CICI的潜在病理生理学的现有文献的审查.
- 基于假设的翻译框架来评估imeglimin对抗化疗引起的认知缺陷的潜在益处.
主要成果:
- 伊梅格林通过增强线粒体功能,减少氧化应激,改善氧化还原平衡来证明神经保护性质.
- 伊梅格林因抑制NF-κB信号传递和减少促炎细胞因子而表现出抗炎作用,可能减轻神经炎症.
- 伊梅格林改善胰岛素敏感性和大脑葡萄糖代谢,解决化疗大脑的"3型糖尿病"概念,增强突触可塑性.
结论:
- 伊梅格林在线粒体和炎症上的多方面的作用表明,它有可能缓解化疗脑病理.
- 进一步的临床前和临床评估对于验证伊梅格林在治疗化疗引起的认知障碍方面的疗效至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
796
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
796
Cognitive Dissonance
37.5K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
922
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
922
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
699
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
699
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
641
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
641
Animal Mitochondrial Genetics
9.3K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K


